News Archives - AINewsWire

MondayNov 17, 2025 11:15 am

AINewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Closes $7.4M Registered Direct as Company Targets Cash Flow Positive in Q1 2026

Beeline Holdings (NASDAQ: BLNE), the digital mortgage lender built for next-generation homeowners, closed a $7.4 million registered direct offering with three funds taking long positions, noting it does not expect to raise additional capital to reach its cash flow positive goal for Q1 2026. The Company reported its lending entity was cash flow positive in October and confirmed its S-1 for an ELOC became automatically effective on Nov. 10, although Beeline is locked out of using the facility for 60 days under the terms of the offering. Any future ELOC use would be limited to a special project or potential…

MondayNov 17, 2025 10:31 am

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Enters $8 Million Tokenization Agreement With Triton Geothermal

Datavault AI (NASDAQ: DVLT) entered a Tokenization Service Agreement with Houston-based Triton Geothermal LLC that includes up to $8 million in tokenization fees tied to a planned $125 million digital token offering, plus five percent of future token transaction fees. The offering is intended to support Triton’s DOE-validated geothermal energy assets, with Datavault AI appointed as exclusive technology provider for tokenization across Triton’s current and future renewable-energy portfolio. The engagement advances Datavault AI’s RWA tokenization strategy as demand grows for compliant digital assets supporting infrastructure and clean-energy projects. To view the full press release, visit https://ibn.fm/mCtuK About Datavault AI Inc.…

MondayNov 17, 2025 9:20 am

AINewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Highlights Operational Progress Following $20 Million in Strategic Investments

Safe Pro Group (NASDAQ: SPAI) reported operational advances across its AI, aerial services and ballistic-protection businesses following more than $20 million in new strategic investments, including a $14 million equity infusion led by Ondas Holdings. The Company noted accelerated development of its SpotlightAI threat-detection platform, new onboard AI integration with Red Cat’s Black Widow drone, rapid prototyping of its SPOTD NODE field-processing solution, expanded Skydio drone operations for a Florida utility, and progress toward NIJ and ISO certification for lightweight armor products. Safe Pro also highlighted recent demining research with humanitarian partners showing significant gains in survey accuracy and efficiency,…

MondayNov 17, 2025 9:00 am

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Reports 148% Q3 Revenue Growth, Expands Global Licensing and RWA Tokenization Pipeline

Datavault AI (NASDAQ: DVLT) reported that third-quarter revenue rose 148% YOY to $2.9 million and 67% sequentially, prompting the Company to raise FY 2025 guidance to $30 million and project more than $200 million in 2026 revenues as licensing monetization accelerates. Recent milestones include a $10 million global licensing deal with Scilex Holding Company, new partnerships with Korea Aerospace University and a Tier-1 defense OEM, and expanding commercial activity across the U.S., Europe and Asia. Datavault AI also noted a rapidly growing pipeline of RWA tokenization licensing opportunities involving assets such as gold, diamonds, rare-earth metals, carbon credits, sugar and…

FridayNov 14, 2025 12:36 pm

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Releases New Datavault Insights Highlighting Execution, Growth and Global Momentum

Datavault AI (NASDAQ: DVLT) released a new Datavault Insights piece detailing the company’s ability to advance commercial deployments, expand global engagement and deliver accelerating revenue growth despite market volatility. The editorial cites approximately 467 percent year-over-year Q2 revenue growth, 2025 guidance of $30 million to $50 million, expected 2026 revenues above $200 million and the pending $150 million strategic investment agreement with Scilex Holdings, while also noting momentum across the VerifyU credentialing platform, ADIO event-based engagement technology and international data monetization initiatives. Datavault Insights is an investor-education and media platform developed in collaboration with Hawk Point Media. To view the…

FridayNov 14, 2025 11:46 am

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Sets Nov. 17 Release for Q3 2025 Financial Highlights

Datavault AI (NASDAQ: DVLT) will report its financial highlights for the third quarter ended Sept. 30, 2025, before U.S. markets open on Monday, Nov. 17, 2025. CEO Nathaniel Bradley and CFO Brett Moyer will host an investor conference call, webcast and Q&A at 8:30 a.m. ET to discuss quarterly results and provide a business update. To view the full press release, visit https://ibn.fm/uvXiT About Datavault AI Inc. Datavault AI (NASDAQ: DVLT) is leading the way in AI experience, valuation, and monetization of assets in the Web 3.0 environment. The company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its…

FridayNov 14, 2025 9:55 am

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) CEO Discusses Stablecoin Adoption and Market Outlook on Schwab Network

Datavault AI (NASDAQ: DVLT) CEO Nathaniel Bradley appeared on Schwab Network to discuss the accelerating adoption of USDC and the growing institutional embrace of stablecoin infrastructure. Bradley noted that Circle’s rising operating costs reflect higher demand, expanding enterprise integration and the rapid evolution of the tokenized economy. He emphasized that stablecoins such as USDC offer efficiency, security and instant settlement capabilities that traditional payment rails cannot match, positioning them as foundational tools for banks, cross-border payments and branded digital currencies. Bradley added that political and regulatory shifts, along with the Genius Act’s provisions for tokenized real-world assets, continue to strengthen…

FridayNov 14, 2025 9:10 am

AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates

HeartBeam (NASDAQ: BEAT) reported third-quarter 2025 results and highlighted continued progress toward commercialization of its 12-lead ECG synthesis software, now in the final stage of FDA 510(k) review with anticipated clearance by year end. The company is advancing commercial readiness, including a new partnership with HeartNexus for 24/7 cardiologist review services, alongside new scientific data presented at AHA Scientific Sessions and HRX Live 2025 and an expanded global IP portfolio of 24 issued patents. For the quarter, R&D expenses were $3.3 million, G&A expenses were $2.0 million, net loss was $5.3 million and cash totaled $1.9 million. HeartBeam will discuss…

ThursdayNov 13, 2025 11:33 am

AINewsBreaks – Databricks Series K Funding Momentum Highlights Strength of Buttonwood Offering Arranged by Joseph Gunnar & Co.

Databricks unprecedented trajectory underpins the recent $17,142,000 membership-interest offering in its Series completed by Buttonwood Group Advisors LLC, for which Joseph Gunnar & Co., LLC served as exclusive placement agent, as the company signs a Series K term sheet valuing it at more than $100 billion to accelerate AI products such as Agent Bricks and Lakebase amid explosive growth that includes surpassing a $4 billion revenue run-rate with AI products contributing over $1 billion, expanding multi-year partnerships with Microsoft and Google Cloud that embed Azure Databricks and Gemini models into its ecosystem, and navigating risks tied to cloud-provider dependencies, regulatory…

ThursdayNov 13, 2025 10:30 am

AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Reports Q3 2025 Results and Highlights AI-Driven Clinical Progress

Lantern Pharma (NASDAQ: LTRN) reported third-quarter 2025 results and advanced multiple AI-driven oncology programs, highlighted by completion of enrollment and achievement of all primary endpoints in the LP-184 Phase 1a trial, which showed a 48% clinical benefit rate at or above the therapeutic dose threshold along with a favorable safety profile and strong biomarker correlations. The company also outlined plans for Phase 1b/2 studies in TNBC, NSCLC with STK11/KEAP1 co-mutations, and bladder cancer, supported by pharmacokinetic data establishing a recommended Phase 2 dose of 0.39 mg/kg. Lantern noted catalyst-rich progress across its pipeline, including regulatory clarity for its pediatric CNS…

AINewsWire provides insights in the emerging sector of Artificial Intelligence.

Contact us: (512) 354-7000

Breaks Categories: News